The Society for Immunotherapy of Cancer (SITC) is pleased to announce the recipients of three 2019 Fellowship Awards, which support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of novel research.
The SITC Fellowship Awards program was established through the society’s Forward Fund, which has committed more than $2 million in Fellowship Award opportunities to deserving young investigators since 2014.
 |
SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies Fellowship Award
Awardee: May Daher, MD
Institution: The University of Texas MD Anderson Cancer Center
Project Title: “CIS checkpoint deletion in cord blood derived iC9.CAR19.IL-15 NK cells to treat B-cell hematologic malignancies”
Award Amount: $100,000 (one year) |
 |
SITC-AstraZeneca Immunotherapy in Lung Cancer (Early Stage NSCLC) Clinical Fellowship Award
Awardee: Chen Zhao, MD
Institution: National Institutes of Health
Project Title: “Investigating microbiota-immune interaction in patients with Non-Small Cell Lung Cancer”
Award Amount: $100,000 (one year) |
 |
SITC's Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship Award (sponsored by Genentech)
Awardee: Yimin (Victor) Du, PhD
Institution: The Salk Institute for Biological Studies
Project Title: “Fine-Tuning Natural Killer Cells to Target T-Cell Resistant Tumors”
Award Amount: $100,000 (one year) |
This year’s SITC Named Fellowship Awards were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP and Genentech, Inc.
The award recipients will be honored during a ceremony at the society’s 34th Annual Meeting on Saturday, Nov. 9, 2019, at the Gaylord National Hotel & Convention Center in National Harbor, Md.